Abdullah Ladha

5PUBLICATIONS
49CO-AUTHORS
PhysiotherapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

|Oct 06, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Yannis K Valtis, Chenyu Lin, David Nemirovsky

|Mar 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy.

Hannah Lust, Liora M Schultz, Soyang Kwon

|Oct 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.

Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar

|Aug 02, 2024
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.

Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand

Pageof 1

Frequent Collaborators

5 joint publications

Lori S Muffly

4 joint publications

Joshua Sasine

4 joint publications

Gregory W Roloff

4 joint publications

Chenyu Lin